308 related articles for article (PubMed ID: 24157405)
61. Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
Sanders SB; Hoskin TL; Stafford AP; Boughey JC
Ann Surg Oncol; 2022 Nov; 29(12):7769-7778. PubMed ID: 35834142
[TBL] [Abstract][Full Text] [Related]
62. Axillary node staging for microinvasive breast cancer: is it justified?
Lyons JM; Stempel M; Van Zee KJ; Cody HS
Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
[TBL] [Abstract][Full Text] [Related]
63. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
64. Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer.
Vargas HI; Vargas MP; Venegas R; Gonzalez KD; Burla M; Mishkin F; Khalkhali I
Am Surg; 2003 Oct; 69(10):886-90. PubMed ID: 14570368
[TBL] [Abstract][Full Text] [Related]
65. Can axillary dissection be avoided in patients with sentinel lymph node metastasis?
Katz A; Niemierko A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Petrucci PE; Flax R; Drogula C; Magnant C
J Surg Oncol; 2006 Jun; 93(7):550-8. PubMed ID: 16705723
[TBL] [Abstract][Full Text] [Related]
66. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.
Huang TW; Kuo KN; Chen KH; Chen C; Hou WH; Lee WH; Chao TY; Tsai JT; Su CM; Huang MT; Tam KW
Int J Surg; 2016 Oct; 34():73-80. PubMed ID: 27562691
[TBL] [Abstract][Full Text] [Related]
67. [Sentinel lymph node biopsy and low axillary node sampling for breast cancer].
Sawai K; Nakajima H; Ohe S; Mizuta N; Sakaguchi K; Hachimine Y
Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):825-30. PubMed ID: 12478860
[TBL] [Abstract][Full Text] [Related]
68. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.
Noguchi M
Eur J Surg Oncol; 2008 Feb; 34(2):129-34. PubMed ID: 17498911
[TBL] [Abstract][Full Text] [Related]
69. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
70. Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study.
Hennigs A; Riedel F; Feißt M; Köpke M; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Heil J
Ann Surg Oncol; 2019 Aug; 26(8):2435-2443. PubMed ID: 31049766
[TBL] [Abstract][Full Text] [Related]
71. Management of Early Node-Positive Breast Cancer in Australia: A Multicentre Study.
Gannan E; Khoo J; Nightingale S; Suhardja TS; Lippey J; Keane H; Tan KJ; Clouston D; Gorelik A; Mann GB;
Breast J; 2016 Jul; 22(4):413-9. PubMed ID: 27095381
[TBL] [Abstract][Full Text] [Related]
72. High intersystem variability for the prediction of additional axillary non-sentinel lymph node involvement in individual patients with sentinel node-positive breast cancer.
van den Hoven I; Kuijt GP; Voogd AC; Roumen RM
Ann Surg Oncol; 2012 Jun; 19(6):1841-9. PubMed ID: 22207045
[TBL] [Abstract][Full Text] [Related]
73. Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients.
Katz A; Niemierko A; Gage I; Evans S; Shaffer M; Smith FP; Taghian A; Magnant C
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):40-4. PubMed ID: 16488555
[TBL] [Abstract][Full Text] [Related]
74. Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer?
Joyce DP; Solon JG; Prichard RS; Power C; Hill AD
Surgeon; 2012 Dec; 10(6):326-9. PubMed ID: 22386798
[TBL] [Abstract][Full Text] [Related]
75. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system.
Kuru B; Sullu Y; Yuruker S; Koray Bayrak I; Ozen N
J BUON; 2016; 21(5):1129-1136. PubMed ID: 27837614
[TBL] [Abstract][Full Text] [Related]
76. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
Stafford AP; Hoskin TL; Day CN; Sanders SB; Boughey JC
Ann Surg Oncol; 2022 Aug; 29(8):4740-4749. PubMed ID: 35451727
[TBL] [Abstract][Full Text] [Related]
77. Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis.
Travagli JP; Atallah D; Mathieu MC; Rochard F; Camatte S; Lumbroso J; Garbay JR; Rouzier R
Eur J Surg Oncol; 2003 May; 29(4):403-6. PubMed ID: 12711299
[TBL] [Abstract][Full Text] [Related]
78. Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort.
Riedel F; Heil J; Feißt M; Rezai M; Moderow M; Sohn C; Schütz F; Golatta M; Hennigs A
Breast Cancer Res Treat; 2019 Sep; 177(2):457-467. PubMed ID: 31236814
[TBL] [Abstract][Full Text] [Related]
79. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
[TBL] [Abstract][Full Text] [Related]
80. Can axillary node dissection be safely omitted in the elderly? A retrospective study on axillary management of early breast cancer in older women.
Esposito E; Sollazzo V; Di Micco R; Cervotti M; Luglio G; Benassai G; Mozzillo P; Perrotta S; Desiato V; Amato B; Forestieri P; Limite G
Int J Surg; 2016 Sep; 33 Suppl 1():S114-8. PubMed ID: 27353842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
